Authors: Uings, IJ Balasubramanian, P McLoughlin, PG Yin, Q Dash, L Beresford, A Kearney, S Barrett, RW McKinnon, M England, BP

Citation: Ij. Uings et al., Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificity, CYTOKINE, 15(1), 2001, pp. 10-19

Authors: Cooke, EL Uings, IJ Xia, CLL Woo, P Ray, KP

Citation: El. Cooke et al., Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation, BIOCHEM J, 359, 2001, pp. 403-410

Authors: Geijsen, N Uings, IJ Pals, C Armstrong, J McKinnon, M Raaijmakers, JAM Lammers, JWJ Koenderman, L Coffer, PJ

Citation: N. Geijsen et al., Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein, SCIENCE, 293(5532), 2001, pp. 1136-1138

Authors: Uings, IJ Farrow, SN

Citation: Ij. Uings et Sn. Farrow, Cell receptors and cell signalling, J CL PATH-M, 53(6), 2000, pp. 295-299

Authors: Uings, IJ Spacey, GD Bonser, RW

Citation: Ij. Uings et al., Effects of the indolocarbazole 3744W on the tyrosine kinase activity of the cytoplasmic domain of the platelet-derived growth factor beta-receptor, CELL SIGNAL, 11(2), 1999, pp. 95-100